On the heels of the CDC’s endorsement of video Directly Observed Therapy (DOT) as equivalent to in-person DOT for tuberculosis treatment, the healthcare tech company formerly known as emocha Mobile Health has made steady moves since its rebrand and $2 million later-stage VC round in 2022.
Scene Health logged a $14 million raise with the SEC earlier this month. Cofounder CEO Sebastian Seiguer described this raise as part of “part of our oversubscribed $17.7 million Series B growth financing round.” That round was led by existing investor ABS Capital Partners, a largely tech- and healthcare-focused private equity fund with offices in DC and the Baltimore suburb of Hunt Valley. Claritas Health Ventures, Healthworx (the innovation and investment arm of CareFirst BlueCross BlueShield), PTX Capital and Kapor Capital also participated in this round.
Seiguer also said the company’s rebranding from emocha to Scene Health, which took place just after its last $2 million fundraising round in October 2022, had no impact on its mission.
READ FULL ARTICLE HERE
